MedPath

A Weight Loss RCT Comparing Keyto vs Weight Watchers

Not Applicable
Completed
Conditions
Overweight and Obesity
Ketogenic Diet
Interventions
Other: Weight Watchers app
Device: Keyto device + app
Registration Number
NCT04165707
Lead Sponsor
University of British Columbia
Brief Summary

Very low-carbohydrate ketogenic diet may have beneficial metabolic and weight loss effects, however, adhering to this diet may be challenging. Keyto is a self-monitoring and app-enhanced intervention to help individuals learn about and monitor their breath acetone (a measure of ketosis) levels to promote dietary change and weight loss. The purpose of this research is to test the Keyto self-monitoring + app intervention against a "standard of care" weight loss dietary app (Weight Watchers). 144 participants will be recruited through Facebook ads, provide online consent, and will be randomized to one of the two conditions. Weight loss after 12 weeks will be assessed as the primary outcome, with weight loss at 24 and 48 weeks being secondary outcomes. Blood samples will be collected at baseline and 12 weeks with optional blood samples at 48 weeks follow up.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
155
Inclusion Criteria
  • Age 18-64
  • Living in the State of California
  • Body mass index (BMI) 27-43
  • Must speak, read, and comprehend English
  • Access to reliable internet and wi-fi
  • Must have a valid email address and phone number
  • Must have an Apple iPhone (iPhone 7 or later, iOS 11 or later) with cellular data plan
  • Must have a kitchen and be willing to cook
  • Willingness to reduce carbohydrate intake to less than 30g/day
  • Willingness to restrict intake of added sugar, bread, grain, rice, pasta, sweets, most fruits, pastries, and other carbohydrates
  • Willingness to comply with a strict diet for 12 months
  • Willingness to eat a diet that is primarily plant and fish-based
  • Interest in losing weight
Read More
Exclusion Criteria
  • HIV or immunocompromised
  • Current or past cancer diagnosis
  • Pregnant, breastfeeding, or planned pregnancy in next 12 months
  • Beginning or ending hormonal contraception in next 12 months
  • Current diagnosis of diabetes
  • History of heart attack or stent
  • Currently taking glucose-lowering drugs, statins, or oral steroids
  • History of gastric bypass surgery or any other weight-loss surgery
  • History of anorexia or bulimia
  • History of mental illness
  • Current smoker or smoked cigarettes within past 12 months
  • Currently eating fewer than 50 g carbohydrates per day
  • Have tried a low-carb, high fat (ketogenic diet) within the past 3 months
  • Recent weight loss or gain of more than 5% body weight in past 6 months
  • Previous experience with the Weight Watchers diet app
  • Experience with a low-carbohydrate of ketogenic diet within past 6 months
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Weight Watchers comparator armWeight Watchers appWeight Watchers app
Keyto intervention armKeyto device + appKeyto device + app
Primary Outcome Measures
NameTimeMethod
Change in body mass at 12 weeks12 weeks from baseline

Change in body mass (in kilograms)

Secondary Outcome Measures
NameTimeMethod
Change in body mass at 24 and 48 weeks24 and 48 weeks from baseline

Change in body mass (in kilograms)

Carbohydrate intake12, 24, and 48 weeks from baseline

Total consumption of carbohydrates in 24 hour period (in grams)

Total fat intake12, 24, and 48 weeks from baseline

Total consumption of fat in 24 hour period (in grams)

Saturated fat intake12, 24, and 48 weeks from baseline

Total consumption of saturated fat in 24 hour period (in grams)

Polyunsaturated fat intake12, 24, and 48 weeks from baseline

Total consumption of polyunsaturated fat in 24 hour period (in grams)

Monounsaturated fat intake12, 24, and 48 weeks from baseline

Total consumption of monounsaturated fat in 24 hour period (in grams)

Total energy intake12, 24, and 48 weeks from baseline

Total energy intake in 24 hour period (in kilocalories)

HbA1C12 and 48 weeks from baseline

Blood test will be used to determine changes in HbA1C

Fasting glucose12 and 48 weeks from baseline

Blood test will be used to determine changes in fasting serum glucose

Fasting insulin12 and 48 weeks from baseline

Blood test will be used to determine changes in fasting serum insulin

Fasting high-sensitivity C-reactive protein12 and 48 weeks from baseline

Blood test will be used to determine changes in fasting serum high-sensitivity C-reactive protein

Fasting homeostasis model assessment of insulin resistance (HOMA-IR)12 and 48 weeks from baseline

Blood test will be used to determine changes in HOMA-IR

Fasting total cholesterol12 and 48 weeks from baseline

Blood test will be used to determine changes in serum total cholesterol

Fasting high-density lipoprotein (HDL) cholesterol12 and 48 weeks from baseline

Blood test will be used to determine changes in serum HDL cholesterol

Fasting lipoprotein fractions12 and 48 weeks from baseline

Blood test will determine changes in serum lipoprotein fractions measured by ion mobility

Fasting lipoprotein (a)12 and 48 weeks from baseline

Blood test will determine changes in serum lipoprotein (a)

Fasting triglycerides12 and 48 weeks from baseline

Blood test will determine changes in serum trigylcerides

Fasting non-HDL cholesterol12 and 48 weeks from baseline

Blood test will determine changes in serum non-HDL cholesterol

Trial Locations

Locations (1)

University of British Columbia

🇨🇦

Kelowna, British Columbia, Canada

© Copyright 2025. All Rights Reserved by MedPath